肿瘤药-话题@MedSci

#肿瘤药#

125篇内容 | 3453人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1537671, encodeId=ec50153e67174, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=Sci China Materials：常用抗肿瘤药物顺铂耐药性研究的新发现, objectType=article, longId=57302, objectId=3c895e302cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c895e302cd, replyNumber=0, likeNumber=70, createdTime=2015-10-17, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c895e302cd, moduleTitle=Sci China Materials：常用抗肿瘤药物顺铂耐药性研究的新发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c895e302cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537670, encodeId=556f153e670f4, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=ASCO 2015：全球肿瘤药物研究新近进展, objectType=article, longId=51827, objectId=fe825182e6f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe825182e6f, replyNumber=0, likeNumber=57, createdTime=2015-06-11, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe825182e6f, moduleTitle=ASCO 2015：全球肿瘤药物研究新近进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe825182e6f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537669, encodeId=22eb153e66980, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=免疫肿瘤药物概述与发展, objectType=article, longId=51761, objectId=ba5251e6119, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba5251e6119, replyNumber=0, likeNumber=75, createdTime=2015-06-08, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba5251e6119, moduleTitle=免疫肿瘤药物概述与发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba5251e6119)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537668, encodeId=1809153e66831, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=ASCO 2015：肿瘤药物争夺战, objectType=article, longId=51645, objectId=efca5164540, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efca5164540, replyNumber=0, likeNumber=68, createdTime=2015-06-06, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efca5164540, moduleTitle=ASCO 2015：肿瘤药物争夺战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efca5164540)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537667, encodeId=ba60153e6675f, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=礼来要拿4亿美元与信达生物合作开发抗肿瘤药, objectType=article, longId=48578, objectId=b649485e899, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b649485e899, replyNumber=0, likeNumber=87, createdTime=2015-03-26, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b649485e899, moduleTitle=礼来要拿4亿美元与信达生物合作开发抗肿瘤药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b649485e899)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537666, encodeId=62ff153e666fa, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=2014年FDA新批准的抗肿瘤药物, objectType=article, longId=46897, objectId=ef0f4689eb5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef0f4689eb5, replyNumber=0, likeNumber=67, createdTime=2015-02-12, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef0f4689eb5, moduleTitle=2014年FDA新批准的抗肿瘤药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef0f4689eb5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537665, encodeId=5ec4153e665c3, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=Int Arch Occ Env HEA：加拿大卫生保健工作者暴露于抗肿瘤药物的风险因素, objectType=article, longId=46487, objectId=cb004648ea2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb004648ea2, replyNumber=0, likeNumber=67, createdTime=2015-02-04, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb004648ea2, moduleTitle=Int Arch Occ Env HEA：加拿大卫生保健工作者暴露于抗肿瘤药物的风险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb004648ea2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537664, encodeId=56fc153e66402, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=靶向抗肿瘤药物的命名, objectType=article, longId=46320, objectId=1bec4632027, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bec4632027, replyNumber=0, likeNumber=81, createdTime=2015-01-30, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bec4632027, moduleTitle=靶向抗肿瘤药物的命名, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bec4632027)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537663, encodeId=3269153e66395, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=Array BioPharma从诺华手中收回肿瘤药binimetinib授权, objectType=article, longId=43726, objectId=c1da43e26eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1da43e26eb, replyNumber=0, likeNumber=58, createdTime=2014-12-10, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1da43e26eb, moduleTitle=Array BioPharma从诺华手中收回肿瘤药binimetinib授权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1da43e26eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537662, encodeId=d9ee153e662b3, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=FDA审查诺华新型血液肿瘤药物, objectType=article, longId=42428, objectId=7f704242867, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f704242867, replyNumber=0, likeNumber=75, createdTime=2014-11-13, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f704242867, moduleTitle=FDA审查诺华新型血液肿瘤药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f704242867)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537661, encodeId=69d7153e661ce, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=Cell Res：抗肿瘤药物可维持胚胎干细胞的自我更新, objectType=article, longId=40353, objectId=a9d940353d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9d940353d8, replyNumber=0, likeNumber=50, createdTime=2014-09-18, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9d940353d8, moduleTitle=Cell Res：抗肿瘤药物可维持胚胎干细胞的自我更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9d940353d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537660, encodeId=ba6c153e660d5, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=百时美施贵宝将与CytomX及Incyte合作共同开发免疫肿瘤药物, objectType=article, longId=35568, objectId=2a283556847, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a283556847, replyNumber=0, likeNumber=69, createdTime=2014-05-31, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a283556847, moduleTitle=百时美施贵宝将与CytomX及Incyte合作共同开发免疫肿瘤药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a283556847)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537659, encodeId=7f40153e65947, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=十三大类抗肿瘤药物靶点汇总, objectType=article, longId=35421, objectId=a78b35421f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a78b35421f9, replyNumber=0, likeNumber=73, createdTime=2014-05-28, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a78b35421f9, moduleTitle=十三大类抗肿瘤药物靶点汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a78b35421f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537658, encodeId=b34a153e658cb, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=全球肿瘤药物市场趋势, objectType=article, longId=35111, objectId=40df3511140, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40df3511140, replyNumber=0, likeNumber=64, createdTime=2014-05-24, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40df3511140, moduleTitle=全球肿瘤药物市场趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40df3511140)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537657, encodeId=a529153e657cb, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=恒瑞医药1.1类肿瘤药环咪德吉获批临床, objectType=article, longId=34820, objectId=7401348205f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7401348205f, replyNumber=0, likeNumber=74, createdTime=2014-05-17, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7401348205f, moduleTitle=恒瑞医药1.1类肿瘤药环咪德吉获批临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7401348205f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537656, encodeId=61c2153e6568f, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=肿瘤药学国际论坛召开, objectType=article, longId=19942, objectId=1de919942c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1de919942c9, replyNumber=0, likeNumber=67, createdTime=2013-06-10, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1de919942c9, moduleTitle=肿瘤药学国际论坛召开, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1de919942c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537655, encodeId=6083153e655fb, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=阿斯利康旗下三个靶向肿瘤药物进入III期临床试验, objectType=article, longId=19185, objectId=10d619185bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10d619185bd, replyNumber=0, likeNumber=86, createdTime=2013-05-25, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10d619185bd, moduleTitle=阿斯利康旗下三个靶向肿瘤药物进入III期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10d619185bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537654, encodeId=89ff153e65429, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=抗肿瘤药物临床试验技术指导原则（第二稿）, objectType=article, longId=17546, objectId=c8751e546ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8751e546ee, replyNumber=0, likeNumber=82, createdTime=2013-04-19, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8751e546ee, moduleTitle=抗肿瘤药物临床试验技术指导原则（第二稿）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8751e546ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537653, encodeId=5d39153e653af, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=JBC：三种抗肿瘤药物或具有抗流感疗效, objectType=article, longId=10011, objectId=c67e100116b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c67e100116b, replyNumber=0, likeNumber=106, createdTime=2012-09-30, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c67e100116b, moduleTitle=JBC：三种抗肿瘤药物或具有抗流感疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c67e100116b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537652, encodeId=896d153e65254, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=EMA批准3种抗肿瘤药驳回1种, objectType=article, longId=8171, objectId=747e81e1a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=747e81e1a1, replyNumber=0, likeNumber=64, createdTime=2012-07-26, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=747e81e1a1, moduleTitle=EMA批准3种抗肿瘤药驳回1种, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=747e81e1a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肿瘤药

2020-05-29

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

Sci China Materials：常用抗肿瘤药物顺铂耐药性研究的新发现

2015-10-17

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

ASCO 2015：全球肿瘤药物研究新近进展

2015-06-11

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

免疫肿瘤药物概述与发展

2015-06-08

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

ASCO 2015：肿瘤药物争夺战

2015-06-06

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

礼来要拿4亿美元与信达生物合作开发抗肿瘤药

2015-03-26

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

2014年FDA新批准的抗肿瘤药物

2015-02-12

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

Int Arch Occ Env HEA：加拿大卫生保健工作者暴露于抗肿瘤药物的风险因素

2015-02-04

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

靶向抗肿瘤药物的命名

2015-01-30

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

Array BioPharma从诺华手中收回肿瘤药binimetinib授权

2014-12-10

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

FDA审查诺华新型血液肿瘤药物

2014-11-13

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

Cell Res：抗肿瘤药物可维持胚胎干细胞的自我更新

2014-09-18

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

百时美施贵宝将与CytomX及Incyte合作共同开发免疫肿瘤药物

2014-05-31

柳叶一刀 (审核中...)

前往app查看评论内容

#肿瘤药#

十三大类抗肿瘤药物靶点汇总

2014-05-28

柳叶一刀 (审核中...)

前往app查看评论内容

#肿瘤药#

全球肿瘤药物市场趋势

2014-05-24

柳叶一刀 (审核中...)

前往app查看评论内容

#肿瘤药#

恒瑞医药1.1类肿瘤药环咪德吉获批临床

2014-05-17

柳叶一刀 (审核中...)

前往app查看评论内容

#肿瘤药#

肿瘤药学国际论坛召开

2013-06-10

柳叶一刀 (审核中...)

前往app查看评论内容

#肿瘤药#

阿斯利康旗下三个靶向肿瘤药物进入III期临床试验

2013-05-25

柳叶一刀 (审核中...)

前往app查看评论内容

#肿瘤药#

抗肿瘤药物临床试验技术指导原则（第二稿）

2013-04-19

柳叶一刀 (审核中...)

前往app查看评论内容

#肿瘤药#

JBC：三种抗肿瘤药物或具有抗流感疗效

2012-09-30

柳叶一刀 (审核中...)

前往app查看评论内容

#肿瘤药#

EMA批准3种抗肿瘤药驳回1种

2012-07-26

科室
- - 订阅+
  - 更多科室
工具
服务